Price History
Investment Checklist
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Trend
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Price Action
Support & Resistance Levels
Volume Analysis
Stop Loss Levels
Fixed Risk
Technical Levels
Moving Averages
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹602.4 Cr | ₹669.8 Cr | — | ₹659.8 Cr |
| Net Profit | ₹154.8 Cr | ₹132.4 Cr | — | ₹90.5 Cr |
| EPS | — | ₹7.94 | ₹9.03 | ₹5.42 |
| Operating Profit | ₹194.9 Cr | ₹220.4 Cr | — | ₹173.6 Cr |
Peer Comparison
Healthcare Service ProviderPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| VIJAYA | Vijaya Diagnostic Centre Limited | ₹1,287.20 | +0.63% |
| THYROCARE | Thyrocare Technologies Limited | ₹528.90 | +1.83% |
| NEPHROPLUS | Nephrocare Health Services Limited | ₹748.15 | -0.42% |
| METROPOLIS | Metropolis Healthcare Limited | ₹530.70 | +2.03% |
| KRSNAA | Krsnaa Diagnostics Limited | ₹534.30 | +0.23% |
| SURAKSHA | Suraksha Diagnostic Limited | ₹268.05 | +0.00% |
| 3BBLACKBIO | 3B Blackbio Dx Limited | ₹1,245.40 | -0.69% |
| HEALTHX | Health X Platform Limited | ₹280.90 | +0.90% |
| CHANDAN | Chandan Healthcare Limited | ₹226.80 | +1.18% |
| INVICTA | Invicta Diagnostic Limited | ₹59.95 | -1.72% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 05 Feb 2026 | Interim Dividend - Rs 3.50 Per Share | INTERIM_DIVIDEND |
| 19 Dec 2025 | Bonus 1:1 | BONUS |
| 07 Nov 2025 | Interim Dividend - Rs 7 Per Share | INTERIM_DIVIDEND |
| 06 Aug 2025 | Interim Dividend - Rs 6 Per Share | INTERIM_DIVIDEND |
| 06 Jun 2025 | Dividend - Rs 6 Per Share | DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for LALPATHLAB
View All
Q4 Results LIVE Updates: Sundram Fasteners profit up 30%; ESAF SFB NII grows 20%
Q4 Results LIVE Updates: Today is the busiest day in terms of quarterly results this week. The big earnings reaction of the day comes from Bajaj Finance where brokerages have raised their targets and even upgraded the stock, along with Waaree Energies, who also issued its guidance for FY27. The biggest result of the day comes from Hindustan Unilever (HUL), followed by Adani twins on the Nifty (Ports & Enterprises), Bajaj Finserv, ACC, Laurus Labs, Dr. Lal Pathlabs, RailTel, Newgen Software and others. Follow for all the Live updates.
